Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Gerber

Showing results (101-110 of 103) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 103 results.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|June 28, 2007
Renaming the DSCR1/Adapt78 gene family as RCAN: regulators of calcineurinKelvin J A Davies, Gennady Ermak, Beverley A Rothermel, et al.
Nature|October 20, 2006
Corneal avascularity is due to soluble VEGF receptor-1Balamurali K Ambati, Miho Nozaki, Nirbhai Singh, et al.
Antibodies (Basel, Switzerland)|September 28, 2019
Development of PF-06671008, a Highly Potent Anti-P-cadherin/Anti-CD3 Bispecific DART Molecule with Extended Half-Life for the Treatment of CancerAdam R Root, Wei Cao, Bilian Li, et al.
Pageof 11

Showing results (101-110 of 103) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 103 results.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|June 28, 2007
Renaming the DSCR1/Adapt78 gene family as RCAN: regulators of calcineurinKelvin J A Davies, Gennady Ermak, Beverley A Rothermel, et al.
Nature|October 20, 2006
Corneal avascularity is due to soluble VEGF receptor-1Balamurali K Ambati, Miho Nozaki, Nirbhai Singh, et al.
Antibodies (Basel, Switzerland)|September 28, 2019
Development of PF-06671008, a Highly Potent Anti-P-cadherin/Anti-CD3 Bispecific DART Molecule with Extended Half-Life for the Treatment of CancerAdam R Root, Wei Cao, Bilian Li, et al.
Pageof 11